Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice
Previous in vitro studies have demonstrated that miR-144 inhibits hepatocellular carcinoma cell proliferation, invasion, and migration. We have shown that miR-144, injected intravenously, is taken up by the liver and induces endogenous hepatic synthesis of miR-144. We hypothesized that administered...
Saved in:
| Main Authors: | Quan He, Fangfei Wang, Takashi Honda, Diana M Lindquist, Jonathan R Dillman, Nikolai A Timchenko, Andrew N Redington |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-10-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317737729 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miR-144/451 in hematopoiesis and beyond
by: Ting Wang, et al.
Published: (2019-05-01) -
The Role of miR‐144 in Inflammatory Diseases: A Review
by: Shukun Hong, et al.
Published: (2025-03-01) -
Protective effect of menthol against diethylnitrosamine-induced hepatocellular carcinoma in mice by downregulating CTNNB1 and HIF-1α
by: Zahra Mollaei, et al.
Published: (2025-06-01) -
Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats
by: Gabriela Velasco-Loyden, et al.
Published: (2017-02-01) -
miR-144-3p targeting FLRT3 in osteogenic differentiation of mandibular bone marrow mesenchymal stem cells
by: Jingjun Tian, et al.
Published: (2025-07-01)